Abstract
The future of OA biomarkers is great. The number of studies currently underway has increased greatly, including longitudinal studies. More research on new biomarkers is underway, and we hope to increase awareness and use of biochemical biomarkers over the next few years. The goal is clear—to move the diagnosis of OA from a radiologic viewpoint back to a pre-radiologic viewpoint and on to the molecular events that initiate cartilage breakdown and joint failure.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
